Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 21, 2022

SELL
$1.91 - $3.98 $10,264 - $21,388
-5,374 Reduced 36.11%
9,507 $20,000
Q4 2021

Feb 01, 2022

SELL
$3.53 - $5.5 $1,962 - $3,058
-556 Reduced 3.6%
14,881 $55,000
Q3 2021

Nov 15, 2021

BUY
$4.99 - $6.55 $219 - $288
44 Added 0.29%
15,437 $77,000
Q2 2021

Jul 30, 2021

BUY
$6.24 - $8.22 $1,747 - $2,301
280 Added 1.85%
15,393 $100,000
Q1 2021

May 03, 2021

BUY
$6.74 - $10.95 $37,784 - $61,385
5,606 Added 58.97%
15,113 $104,000
Q4 2020

Jan 28, 2021

BUY
$3.75 - $10.56 $19,267 - $54,257
5,138 Added 117.6%
9,507 $97,000
Q1 2020

May 06, 2020

BUY
$1.46 - $7.19 $6,378 - $31,413
4,369 New
4,369 $15,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $354M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.